By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Spring Bank Pharmaceuticals, Inc. 

113 Cedar Street
Ste S-7
Milford  Massachusetts  01757  U.S.A.
Phone: 508-473-5993 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Spring Bank Pharmaceuticals, Inc. To Present At The 18th Annual Rodman & Renshaw Global Investment Conference In New York City On September 13th, 2016 8/23/2016 8:03:47 AM
Spring Bank Pharmaceuticals, Inc. To Ring The Nasdaq Stock Market Opening Bell 8/2/2016 8:39:24 AM
Spring Bank Pharmaceuticals, Inc. Appoints Dr. Todd C. Brady To Its Board Of Directors 7/29/2016 8:29:14 AM
Spring Bank Pharmaceuticals, Inc. Reports Preclinical Data On The Use Of SB 9200 With Entecavir In The Woodchuck Model Of HBV 12/8/2015 11:46:30 AM
Spring Bank Pharmaceuticals, Inc. Announces Clinical Trial Collaboration With Gilead (GILD) For Hepatitis B (HBV) Phase 2 Clinical Trial 11/19/2015 6:12:21 AM
Spring Bank Pharmaceuticals, Inc. Presents Positive Phase 1 Data On SB 9200 At The 2015 American Association For The Study Of Liver Diseases Annual Meeting 11/16/2015 7:38:06 AM
Spring Bank Pharmaceuticals, Inc. Names Nezam Afdhal, MD As Chief Medical Officer 11/9/2015 8:24:28 AM
Spring Bank Pharmaceuticals, Inc. Announces Presentation Of Results From Phase I Clinical Trial Supporting The Novel Mechanism Of Action Of SB 9200 In Patients With Hepatitis C At The Liver Meeting 10/13/2015 7:01:21 AM
Spring Bank Pharmaceuticals, Inc. Appoints Martin Driscoll As President And Chief Executive Officer 8/17/2015 6:38:27 AM
Spring Bank Pharmaceuticals, Inc. Presents Preclinical And Clinical Data On Immunomodulatory Agent SB 9200 At The 2015 Annual Meeting Of The European Association For The Study Of The Liver 4/27/2015 6:32:22 AM
123
//-->